Pharmacokinetic study of DSP-1958
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 12 May 2017
At a glance
- Drugs Thiotepa (Primary)
- Indications Brain cancer; Lymphoma; Solid tumours
- Focus Pharmacokinetics
- Sponsors Sumitomo Dainippon Pharma
- 21 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 11 Jan 2017 Status changed from not yet recruiting to recruiting.
- 16 Nov 2016 New trial record